A Study of SHR-2173 in Participants With Primary IgA Nephropathy

Clinical trial NCT07354932 · RECRUITING

Trial details

NCT number: NCT07354932
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary IgA Nephropathy

Start date: 2026-03-09
Primary completion: 2027-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.